MDPI and ACS Style
Santini-Oliveira, M.; Machado Pinto, P.; Santos, T.d.; Vilar, M.M.; Grinsztejn, B.; Veloso, V.; Paes-de-Almeida, E.C.; Amaral, M.A.Z.; Ramos, C.R.; Marroquin-Quelopana, M.;
et al. Development of the Sm14/GLA-SE Schistosomiasis Vaccine Candidate: An Open, Non-Placebo-Controlled, Standardized-Dose Immunization Phase Ib Clinical Trial Targeting Healthy Young Women. Vaccines 2022, 10, 1724.
https://doi.org/10.3390/vaccines10101724
AMA Style
Santini-Oliveira M, Machado Pinto P, Santos Td, Vilar MM, Grinsztejn B, Veloso V, Paes-de-Almeida EC, Amaral MAZ, Ramos CR, Marroquin-Quelopana M,
et al. Development of the Sm14/GLA-SE Schistosomiasis Vaccine Candidate: An Open, Non-Placebo-Controlled, Standardized-Dose Immunization Phase Ib Clinical Trial Targeting Healthy Young Women. Vaccines. 2022; 10(10):1724.
https://doi.org/10.3390/vaccines10101724
Chicago/Turabian Style
Santini-Oliveira, MarÃlia, PatrÃcia Machado Pinto, Tatiane dos Santos, Mônica Magno Vilar, Beatriz Grinsztejn, Valdilea Veloso, Elan C. Paes-de-Almeida, Maria A. Z. Amaral, Celso R. Ramos, Miryam Marroquin-Quelopana,
and et al. 2022. "Development of the Sm14/GLA-SE Schistosomiasis Vaccine Candidate: An Open, Non-Placebo-Controlled, Standardized-Dose Immunization Phase Ib Clinical Trial Targeting Healthy Young Women" Vaccines 10, no. 10: 1724.
https://doi.org/10.3390/vaccines10101724